BioOnco provide more efficient processes for biopharmaceuticals at lower costs than is possible using conventional biomanufacturing production technology. Our team of expert scientists possessing extensive knowledge of regulatory and biopharmaceutical requirements. Our services include
Mammalian cell culture
BioOnco specializes in the production of large batches of adherent and non-adherent mammalian cells that express cell surface receptors and proteins of interest. Cells are grown according to your exact protocol. The pilot production suites, equipment and supporting infrastructure, control systems etc. are designed to closely match those in the company's cGMP production suites to facilitate rapid technology transfer from process development into production
more ...
Microbial fermentation
Microbial Fermentation service offers to the industry its renowned know-how and facilities to efficiently and confidentially develop, optimize and scale up microbial fermentation processes, and to recover, purify and characterize microbial products.
more ...
DNA/RNA Isolation Services
BioOnco offers high-quality RNA/ DNA isolation services for various applications such as PCR, cloning, cDNA or genomic library construction. Our staff has experience in isolating custom DNA and RNA from a variety of specimens
more ...
Protein expression and purification
We offer a number of expression systems designed to meet specific goals, ranging from expression of tagged proteins as antigens for antibody generation to production of biopharmaceuticals for clinical use. Gene synthesis, generating expression construct, establishing stable cell lines, generating recombinant viruses, small & large scale expression and purification can be performed.
more ...
Antibody Development
Antibody Development will provide custom designed monoclonal and polyclonal antibodies. Services include design of antigens, immunization and screening strategies; hybridoma cell line production and optimization; cloning, expression and engineering of single chain antibody variable fragments. Several mono and polyclonal antibodies that we have developed are available to researchers at other institutions.
more ...
